# Autologous Bedside CD19 CAR T-cell Therapy for B-ALL

> **NCT07277504** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **The General Hospital of Western Theater Command** · enrollment: 50 (estimated)

## Conditions studied

- B-Cell Acute Lymphoblastic Leukemia, Adult

## Interventions

- **DRUG:** CD19 CAR T cells

## Key facts

- **NCT ID:** NCT07277504
- **Lead sponsor:** The General Hospital of Western Theater Command
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07277504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07277504, "Autologous Bedside CD19 CAR T-cell Therapy for B-ALL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07277504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*